Search

Topics

Western News

Schulich School of Medicine and Dentistry

Schulich researchers asked ChatGPT for medical diagnoses. Here’s what they found

Schulich researchers asked ChatGPT for medical diagnoses. Here’s what they found

For symptoms like a runny nose and a cough, some might think it’s a common cold. It doesn’t warrant a doctor’s visit, so they turn to Google and WebMD for additional reassurance. Now, with advancements in AI, some might be tempted to switch from “Dr. Google” to “Dr. ChatGPT,” but can OpenAI’s AI-powered chatbot provide accurate medical advice?  Researchers from Western University set out to answer that question and explore whether ChatGPT is capable of becoming a reliable resource in health care and medical education. The study, led by Schulich School of Medicine & Dentistry assistant professor Dr. Amrit Kirpalani, was recently published in PLOS One and found that ChatGPT was only 49 per cent accurate when it came to providing the right diagnosis.   While they determined ChatGPT is not yet ready to be used as a reliable medical diagnostic tool for complicated cases, their study did find it was able to take complex medical topics and synthesize them in an easy-to-understand manner, which could be beneficial for instructors and health-care providers to deliver medical information in a digestible format. 
Dr. Amrit Kirpalani

Dr. Amrit Kirpalani

“To me, the most relevant finding is that ChatGPT delivered its answers in a very simple and easy-to-understand way,” said Kirpalani. “I think that’s important because you can see the potential for it to be used as a great tool to help people learn and understand medical cases – but it can also be very convincing even when it’s wrong.  The study asked ChatGPT to diagnose 150 cases through Medscape Clinical Challenges, which are designed to test the diagnostic skills of health-care professionals. Medscape is a public platform with many complex cases, where clinicians vote on what they think is the right answer. The research team, which included third-year medical students Ali Hadi, Edward Tran and Branavan Nagarajan, created prompts asking ChatGPT to choose the correct diagnosis in a multiple-choice format and to provide a rationale.   The chatbot was given information including patients’ histories, physical examination results, and laboratory or imaging test results. The researchers found it struggled with interpreting test results and sometimes overlooked critical information that was relevant to the diagnosis. However, the chatbot was helpful in providing next diagnostic steps and making medical information more accessible.   

More research needed to ‘use AI responsibly’ 

It is clear from the study that further research and advancements are needed before AI can be used as another tool to help with medical diagnoses. And as new AI models advance and improve, Kirpalani emphasizes the importance of AI literacy. 

“AI literacy is important for patients, for providers, for educators and for students because we need to understand how we can use AI responsibly and how it can be applied and leveraged for health care and medical education purposes.” – Dr. Amrit Kirpalani, Schulich School of Medicine & Dentistry professor

Regardless of the accuracy of these online resources, Kirpalani stressed the need to evaluate and double check responses from the internet against reliable, peer-reviewed sources.   “I would say we’re maybe already at the point where we need guidance around prompt engineering – where they structure an instruction that can be interpreted and understood by a generative AI model,” said Kirpalani. “We are going to need a lot of oversight on how it’s being used to ensure patient safety and to make sure [this kind of AI technology] will be thoughtfully rolled out.”   
Youth vaping problem nets research dollars

Youth vaping problem nets research dollars

Vaping among teenaged Canadians has doubled in the past two years – a troubling trend that three Western researchers will examine in depth with new funding from the CIHR.

Four new Canada Research Chairs for Western, two renewed

Four new Canada Research Chairs for Western, two renewed

Western is home to four new Canada Research Chairs, professors whose work will have global impact on autism, data science and children’s learning. Two chairs, in business sustainability and neuroscience, have been renewed. Celebrating its 20thanniversary this year,...

Alzheimer’s researcher goes back in time to move forward in diagnosis

Alzheimer’s researcher goes back in time to move forward in diagnosis

Shawn Whitehead will be doing some medical time traveling as he works to pinpoint the roots of cognitive impairment, including Alzheimer’s disease. The Schulich Medicine & Dentistry professor recently received a grant to study brain inflammation as a potential predictor of cognitive decline.

Researchers make first steps towards cure for HIV

Researchers make first steps towards cure for HIV

A new strategy deployed against HIV by Western researchers has been able to pull the virus out of hiding in cells and expose it to potential attack from the immune system or open it to further treatment.

Read. Watch. Listen. with Ken Milne

Read. Watch. Listen. with Ken Milne

It starts with an earthquake, birds and snakes and aeroplanes, and Schulich School of Medicine and Dentistry professor Ken Milne is not afraid when he takes a turn on Read. Watch. Listen.

App bridges need by matching volunteers, seniors

Living a too-distant border away from his grandmother, Medical Sciences/Biology student Harshil Shah worried about how some isolated, elderly people were managing without the help they needed during the COVID-19 pandemic.

Read. Watch. Listen. with Mel Goodale

Read. Watch. Listen. with Mel Goodale

Transport yourself beyond pandemic isolation and into parallel worlds both near and far when Western neuroscientist Mel Goodale takes a turn on Read. Watch. Listen.

Study hints at early sign of Alzheimer’s degeneration

Study hints at early sign of Alzheimer’s degeneration

Researchers have moved one step closer to identifying targets for brain degeneration that occur decades before symptoms of Alzheimer’s disease appear – a much sought-after clue that might open the door to early treatment.